SPPL2B
Basic information
Region (hg38): 19:2328615-2355095
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPPL2B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 5 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 2 | 0 |
Variants in SPPL2B
This is a list of pathogenic ClinVar variants found in the SPPL2B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-2334713-A-G | not specified | Likely benign (Nov 05, 2021) | ||
19-2339960-C-G | not specified | Uncertain significance (Sep 30, 2021) | ||
19-2339961-T-A | not specified | Likely benign (Sep 30, 2021) | ||
19-2340135-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
19-2353033-C-T | not specified | Uncertain significance (Sep 15, 2021) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane signal peptides in the hydrophobic plane of the membrane. Functions in ITM2B and TNF processing (PubMed:16829952, PubMed:16829951, PubMed:17965014, PubMed:19114711, PubMed:22194595). Catalyzes the intramembrane cleavage of the anchored fragment of shed TNF-alpha (TNF), which promotes the release of the intracellular domain (ICD) for signaling to the nucleus (PubMed:16829952, PubMed:16829951). May play a role in the regulation of innate and adaptive immunity (PubMed:16829952). Catalyzes the intramembrane cleavage of the simian foamy virus processed leader peptide gp18 of the envelope glycoprotein gp130 dependently of prior ectodomain shedding by furin or furin-like proprotein convertase (PC)-mediated cleavage proteolysis (PubMed:23132852). {ECO:0000269|PubMed:16829951, ECO:0000269|PubMed:16829952, ECO:0000269|PubMed:17965014, ECO:0000269|PubMed:19114711, ECO:0000269|PubMed:22194595, ECO:0000269|PubMed:23132852}.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.77
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- Y
- hipred_score
- 0.702
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.341
Mouse Genome Informatics
- Gene name
- Sppl2b
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- membrane protein ectodomain proteolysis;regulation of tumor necrosis factor-mediated signaling pathway;membrane protein intracellular domain proteolysis;membrane protein proteolysis;regulation of immune response
- Cellular component
- Golgi membrane;nucleoplasm;lysosomal membrane;centrosome;plasma membrane;endosome membrane;actin cytoskeleton;membrane;Golgi-associated vesicle membrane;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane
- Molecular function
- protein binding;aspartic endopeptidase activity, intramembrane cleaving;protein homodimerization activity